Detailed sources: https://docs.google.com/document/d/1ksVvFuR0IttxzH6zoASSYy7Z…b62ckaanow.
Based on the report: Situational Awareness — by Leopold Aschenbrenner https://situational-awareness.ai/from-agi-to-superintelligence/
Hi, I’m Drew! Thanks for watching smile
I also post mid memes on Twitter: https://twitter.com/PauseusMaximus.
Also, I meant to say Cortés conquered the Aztecs, not the Incas.
Cobras kill thousands of people a year worldwide and perhaps a hundred thousand more are seriously maimed by necrosis – the death of body tissue and cells – caused by the venom, which can lead to amputation.
Current antivenom treatment is expensive and does not effectively treat the necrosis of the flesh where the bite occurs.
“Our discovery could drastically reduce the terrible injuries from necrosis caused by cobra bites – and it might also slow the venom, which could improve survival rates,” said Professor Greg Neely, a corresponding author of the study from the Charles Perkins Centre and Faculty of Science at the University of Sydney.
Georgetown Lombardi, Washington’s only National Cancer Institute-designated Comprehensive Cancer Center, serves as the research engine for MedStar Health, Georgetown University’s clinical partner. Georgetown Lombardi is also an NCI-recognized research consortium with John Theurer Cancer Center of Hackensack Meridian Health in Bergen County, New Jersey.
They have a blog with alot of useful cancer information you can share. There is info about them circulating about cancer vaccines and clinical trials. Check em out:
(You can repost their posts or contact them to recieve information from them directly. Lombardi Comprehensive Cancer Center 3,800 Reservoir Rd. NW Washington D.C. 20,057 Phone: 202−444−2223)
A study published in Nature Biotechnology reveals a powerful new use for artificial intelligence: designing small, drug-like molecules that can stick to and break down harmful proteins in the body — even when scientists don’t know what those proteins look like. The breakthrough could lead to new treatments for diseases that have long resisted traditional drug development, including certain cancers, brain disorders, and viral infections.
The study was published on August 13, 2025 by a multi-institutional team of researchers from McMaster University, Duke University, and Cornell University. The AI tool, called PepMLM, is based on an algorithm originally built to understand human language and used in chatbots, but was trained to understand the “language” of proteins.
In 2024, the Nobel Prize in Chemistry was awarded to researchers at Google DeepMind for developing AlphaFold, an AI system that predicts the 3D structure of proteins – a major advance in drug discovery. But many disease-related proteins, including those involved in cancer and neurodegeneration, don’t have stable structures. That’s where PepMLM takes a different approach – instead of relying on structure, the tool uses only the protein’s sequence to design peptide drugs. This makes it possible to target a much broader range of disease proteins, including those that were previously considered “undruggable.”